NCT02330302

Brief Summary

Hip fractures are common in our elderly population and is associated with pain before and after surgery. The current pain management for patients who have undergone surgery for hip fractures include a combination of oral painkillers, opioids (eg morphine) and regional anaesthesia techniques, which involves the injection of local anaesthetic drugs near nerves supplying the hip joint to numb the operation site. As opioids have many side effects, especially in the elderly patients, regional anaesthesia techniques can help to reduce the use of opioids and the related side effects. This may enhance their recovery and length of hospital stay

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 31, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 1, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
Last Updated

January 25, 2018

Status Verified

January 1, 2018

Enrollment Period

7 months

First QC Date

December 31, 2014

Last Update Submit

January 23, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain scores

    resting and dynamic pain scores are obtained pre-intervention, 30mins post intervention (and on positioning for spinal anaesthesia), 1 hr post-operatively and at 24hrs post intervention

    up to 24 hours

Secondary Outcomes (1)

  • opioid requirement/consumption

    for first 24 hrs (including intra operatively) following intervention

Other Outcomes (1)

  • complications associated with intervention

    at 24 hrs post intervention

Study Arms (2)

Femoral nerve block

ACTIVE COMPARATOR

Procedure: Ultrasound-guided femoral nerve block Drug: Ropivacaine 0.5% 30mls

Drug: Ropivacaine

Fascia Iliaca block

ACTIVE COMPARATOR

Procedure: Ultrasound-guided suprainguinal approach to fascia iliaca block Drug: Ropivacaine 0.5% 30mls

Drug: Ropivacaine

Interventions

Ultrasound-guided femoral nerve block with Ropivacaine 0.5% 30mls

Also known as: naropin
Femoral nerve block

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for surgical fixation of hip fracture
  • Patients with isolated inter-trochantric fracture
  • American Society of Anesthesiologists (ASA) physical status 1 to 3
  • Patients who are able to give their own consent

You may not qualify if:

  • Patients unable to give consent or inability to communicate/ cooperate
  • Patients with regular consumption of strong opioids (morphine, oxycodone) or steroids
  • Patients with allergy to local anaesthetics or any drugs included in the study
  • Patients with contraindications to spinal anaesthesia such as coagulation disorders/ thrombocytopenia and local infection at site of injection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Changi General Hospital

Singapore, 529889, Singapore

Location

MeSH Terms

Conditions

Hip Fractures

Interventions

Ropivacaine

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Yean Chin Lim, MBBS, MMed

    Changi General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 31, 2014

First Posted

January 1, 2015

Study Start

August 1, 2014

Primary Completion

March 1, 2015

Study Completion

August 1, 2015

Last Updated

January 25, 2018

Record last verified: 2018-01

Locations